May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
OPA1 Mutations and Clinical Phenotype in Japanese Patients with Dominant Optic Atrophy
Author Affiliations & Notes
  • M. Nakamura
    Ophthalmology, Nagoya Univ School of Medicine, Nagaya, Japan
  • S. Ueno
    Ophthalmology, Nagoya Univ School of Medicine, Nagaya, Japan
  • J. Lin
    Ophthalmology, Nagoya Univ School of Medicine, Nagaya, Japan
  • R. Asaoka
    Ophthalmology, Hamamatsu Univ School of Medicine, Hamamatsu, Japan
  • Y. Hotta
    Ophthalmology, Hamamatsu Univ School of Medicine, Hamamatsu, Japan
  • H. Terasaki
    Ophthalmology, Nagoya Univ School of Medicine, Nagaya, Japan
  • Y. Miyake
    Ophthalmology, Nagoya Univ School of Medicine, Nagaya, Japan
  • Footnotes
    Commercial Relationships  M. Nakamura, None; S. Ueno, None; J. Lin, None; R. Asaoka, None; Y. Hotta, None; H. Terasaki, None; Y. Miyake, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2460. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Nakamura, S. Ueno, J. Lin, R. Asaoka, Y. Hotta, H. Terasaki, Y. Miyake; OPA1 Mutations and Clinical Phenotype in Japanese Patients with Dominant Optic Atrophy . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2460.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Autosomal dominant optic atrophy (DOA) is characterized by symmetric optic atrophy associated with reduced corrected visual acuity, central or centrocaecal stroma, and color vision disturbances. The disease is genetically heterogeneous, and the OPA1 gene has been identified as a causative gene. The aim of this study was to determine mutations of the OPA1 gene in Japanese patients with DOA and to describe the clinical features of the patients. Methods: Nineteen separate Japanese families with optic atrophy were examined. Seven families had an autosomal dominant inheritance pattern, and 11 probands were considered to be sporadic from their family histories. The inheritance pattern could not be determined in one family. Genomic DNA was extracted from leukocytes of the peripheral blood, and exons 1 through 28 of the OPA1 gene were amplified by polymerase chain reaction and directly sequenced. A complete ophthalmologic examination was performed including best–corrected visual acuity, visual fields, slit–lamp and fundus examination, fundus photography, and color vision testing. Results: Ten heterozygous mutations in the OPA1 gene were identified in 12 Japanese families with DOA. Eight of the mutations were novel. Six of the seven autosomal dominant families as well as 5 out of 11 the sporadic probands had a mutation. Family examination of 2 sporadic probands revealed that the true hereditary pattern in the families was autosomal dominant. The identified mutations included five deletions/insertions, three nonsense, one splice site, and one missense mutations. The frequently–detected mutation (c.2708delTTAG) in Caucasians, was found in three families. Clinically, the severity varied considerably from legally blind to asymptomatic patients. Conclusions: OPA1 gene mutations are causative in most Japanese families with DOA. Sporadic cases with optic atrophy are caused by OPA1 mutations at a relatively high frequency in Japanese population.

Keywords: mutations • optic disc • degenerations/dystrophies 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×